"100% of participants saw improvements in their Alzheimers when given mushrooms". That title is much more attention grabbing.

All this study proves is the 1 person who was studied out of the 55 million people who have Alzheimer's, saw a temporary improvement by taking a high dose of mushrooms.

I don't "do drugs" anymore. From now on, I'm "initiating a single-person study."

As usual, a case study is basically the bottom of the barrel you can get for efficacy of a treatment that's still published science. It doesn't mean it's bad science (it can often be quite useful for establishing future studies); it just means that it really shouldn't be advertised to the general public until there's e.g. a good meta-analysis.

Anyway, with that said, here's a link to the case study since CTV's seems to be malformatted.

Single person study? Sounds totally legit and should be immediately rolled out to everyone. Clearly nothing bad could happen. /s

Doesn’t “single person study” effectively mean they didn't die?